Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-04-10 5:00 pm Purchase | 2023-04-06 | 13G | Ascendis Pharma A/S ASND | RA Capital Management, L.P. | 9,967,172 17.400% | 3,009,993 (+43.26%) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | Ascendis Pharma A/S ASND | RA Capital Management, L.P. | 6,957,179 12.200% | -610,721 (-8.07%) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | Ascendis Pharma A/S ASND | BAKER BROS. ADVISORS LP | 4,954,855 8.700% | 413,251 (+9.10%) | Filing History |
| 2023-02-14 12:38 pm Sale | 2022-12-31 | 13G | Ascendis Pharma A/S ASND | T. Rowe Price Associates, Inc. | 3,709,841 6.500% | -1,051,352 (-22.08%) | Filing History |
| 2023-02-14 09:33 am Purchase | 2022-12-31 | 13G | Ascendis Pharma A/S ASND | AVORO CAPITAL ADVISORS LLC | 3,100,000 5.400% | 3,100,000 (New Position) | Filing History |
| 2023-02-10 10:01 am Purchase | 2022-12-31 | 13G | Ascendis Pharma A/S ASND | JANUS HENDERSON GROUP PLC JHG | 3,643,955 6.400% | 423,990 (+13.17%) | Filing History |
| 2023-02-10 09:11 am Sale | 2022-12-31 | 13G | Ascendis Pharma A/S ASND | Artisan Partners Limited Partnership | 6,920,356 12.100% | -1,020,078 (-12.85%) | Filing History |
| 2023-02-09 08:23 am Sale | 2023-02-09 | 13G | Ascendis Pharma A/S ASND | FMR LLC | 5,229,070 9.271% | -126,873 (-2.37%) | Filing History |
| 2023-02-06 2:36 pm Sale | 2022-12-30 | 13G | Ascendis Pharma A/S ASND | Wellington Management Group LLP | 3,076,012 5.400% | -992,464 (-24.39%) | Filing History |
| 2023-02-01 7:36 pm Purchase | 2022-12-30 | 13G | Ascendis Pharma A/S ASND | Westfield Capital Management Company, L.P. | 3,158,168 5.540% | 3,158,168 (New Position) | Filing History |
| 2022-02-14 4:13 pm Purchase | 2021-12-31 | 13G | Ascendis Pharma A/S ASND | BAKER BROS. ADVISORS LP | 4,541,604 8.000% | 1,001,334 (+28.28%) | Filing History |
| 2022-02-14 4:11 pm Purchase | 2021-12-31 | 13G | Ascendis Pharma A/S ASND | RA Capital Management, L.P. | 7,567,900 13.300% | 1,702,562 (+29.03%) | Filing History |
| 2022-02-14 2:34 pm Sale | 2021-12-31 | 13G | Ascendis Pharma A/S ASND | T. Rowe Price Associates, Inc. | 4,761,193 8.300% | -1,857,849 (-28.07%) | Filing History |
| 2022-02-10 2:12 pm Purchase | 2021-12-31 | 13G | Ascendis Pharma A/S ASND | JANUS HENDERSON GROUP PLC JHG | 3,219,965 5.700% | 211,136 (+7.02%) | Filing History |
| 2022-02-09 09:09 am Sale | 2022-02-08 | 13G | Ascendis Pharma A/S ASND | FMR LLC | 5,355,943 9.496% | -19,180 (-0.36%) | Filing History |
| 2022-02-04 09:06 am Purchase | 2021-12-31 | 13G | Ascendis Pharma A/S ASND | Wellington Management Group LLP | 4,068,476 7.150% | 666,918 (+19.61%) | Filing History |
| 2022-02-04 06:09 am Purchase | 2021-12-31 | 13G | Ascendis Pharma A/S ASND | Artisan Partners Limited Partnership | 7,940,434 13.900% | 2,172,907 (+37.67%) | Filing History |
| 2021-05-10 1:11 pm Purchase | 2021-05-07 | 13G | Ascendis Pharma A/S ASND | FMR LLC | 5,375,123 10.000% | 33,514 (+0.63%) | Filing History |
| 2021-02-16 5:09 pm Purchase | 2020-12-31 | 13G | Ascendis Pharma A/S ASND | BAKER BROS. ADVISORS LP | 3,540,270 6.600% | 150,000 (+4.42%) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | Ascendis Pharma A/S ASND | RA Capital Management, L.P. | 5,865,338 10.900% | 46,476 (+0.80%) | Filing History |